RKRajesh N. Kalaria

Rajesh N. Kalaria

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Rajesh N. Kalaria has a total of 580 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Coronary artery disease and cardiac pathology in cerebral small vessel disease and post‐stroke dementia: Implications for Alzheimer's disease

    by Yoshiki Hase, Tuomo Polvikoski, Dan Jobson, Klarizze Premarion, Ethan Tutter, Erika Kitajima, Pazhanichamy Kalailingam, Xavier Gallart‐Palau, Siu Kwan Sze, Louise Allan, et al.

    BACKGROUND: The relationships between coronary or cardiac pathology, cerebral small vessel disease (SVD), Alzheimer's disease pathology, and vascular cognitive impairment and dementia (VCID) remain unclear. METHODS: We performed a clinicopathological study in 75 stroke patients enrolled in the prospective Cognitive Function After Stroke (CogFAST) cohort. Comprehensive histopathological examination was performed to characterize the spectrum of pathologies in samples of the main coronary arteries (CorA), and cardiac and brain tissues from stroke survivors diagnosed with post‐stroke dementia (PSD; mean age, standard deviation, range, % sex; 88 ± 8 years, 65–99, 55% female) or without dementia (PSND; 86 ± 4 years, 79–94, 45% female). RESULTS: All subjects exhibited occult or obstructive CorA disease with > 50% clinically defined stenosis in at least one of the main coronary arteries. Linear correlation analysis showed that CorA stenosis was positively related to internal carotid artery stenosis ( P < 0.03). CorA stenosis was not associated with pathological measures of cerebral SVD per se or neurodegenerative disorders. Cardiac pathology was highly prevalent, with ≈ 80% of the subjects having at least one feature of cardiac pathology including fibrosis, disarray, and myocyte damage and 62% exhibiting myocardial infarcts. CorA stenosis was associated with higher cardiac pathology score, which was also related to cardiac sympathetic denervation and α‐synuclein accumulation in the stellate ganglia. We noted low heart weights ( P < 0.001), greater myocardial infarcts ( P < 0.001), and greater general cardiac atrophy ( P = 0.024) in the PSD compared to the PSND group. CONCLUSIONS: Our findings suggest there is a relationship between CorA disease and carotid artery disease and that cardiac pathology in elderly stroke survivors may be a factor in the development of delayed dementia after the stroke injury and VCID.

  • Cognitive Outcomes After Reperfusion Therapy for Acute Ischaemic Stroke: A Systematic Review and Meta-analysis and the PRECISE-ACTION Framework for Transdisciplinary Cognitive Management

    by Samprithi Raja, Robert Weissert, Zeljka Calic, Pravin Thomas, Jasvinder Chawla, Susana Mederer Hengstl, Ivica Smokovski, Olga Golubnitschaja, Tomotaka Tanaka, Kevin J. Spring, et al.


  • VasCog-2-WSO Criteria for Vascular Cognitive Impairment and Dementia

    by Rajesh N. Kalaria, Perminder S. Sachdev

  • Open Access

    Astrocyte-driven small vessel disease is an early, amyloid-independent feature of PSEN1 E280A familial Alzheimer’s disease

    by Jessica Lisa Villalba-Moreno, Yassir El-Amri, Keun-Young Kim, Nelson David Villalba-Moreno, Mohsin Shafiq, Carolina Ortiz-Cordero, Shiwei Wang, J Alejandro Ossa, Isaura Suarez-Uribe, Duvan Cardona-Madrigal, et al.

    Cerebral Small vessel disease (cSVD) is a prevalent feature of Alzheimer’s disease (AD) pathology. Whether this pathology is a late consequence of amyloid and tau accumulation or an early, direct effect of PSEN1 dysfunction has remained unresolved. We found that it is more severe in familial AD (FAD) caused by E280A mutation in presenilin 1 (PSEN1). These cases present with a distinctive proteomic signature, associated with pathological features, more dysregulated in the occipital cortex (OC) compared to the frontal cortex (FC), and characterized by multiple dysregulated proteins involved in extracellular matrix (ECM) and RNA-associated processes. This proteomic fingerprint was associated with abnormal collagen build up, ECM disorganization, and signatures of aberrant angiogenesis. Six months old transgenic knock-in mice homozygous for Psen1 E280A mutation (PSEN1Ki) also showed a similar phenotype with microvascular tortuosity and proteomic changes. Critically, these mice develop neither Aβ plaques nor tau tangles, indicating that the shared microvascular and RNA-associated changes are direct consequences of PSEN1 dysfunction rather than downstream effects of amyloid pathology. Remarkably, dysregulated RNA-associated protein networks overlapped between FAD and PSEN1Ki mice. Cerebral microvessels microstructure in PSEN1Ki mice at two months and six months showed abnormal astrocytic end-feet with lamellar deposits implicating blood-brain barrier damage. Finally, single nuclei transcriptomic analysis of AD patients and controls showed similar abnormal astrocytes in both sporadic and familial variants, but FAD astrocytes expressed dysregulated genes identified in the proteomic analyses, such as GLUL, APOE, and CLU. Our findings suggest that cSVD is an early pathological event in PSEN1 FAD and that is driven by abnormal RNA-associated processes and astrocytic dysfunction.

  • Open Access

    Plasma proteomic profiles of Alzheimer’s disease and neurodegeneration in African cohorts

    by Ilaria Pola, Tolulope Akinyemi, Kubra Tan, Oladotun Olalusi, Wiebke Traichel, Giulia Giacomucci, Joseph Yaria, Nesrine Rahmouni, Gabriel Ogunde, Olabode Oguntiloye, et al.

    Alzheimer’s disease and related dementia (ADRD) represents a growing public health burden, especially in low- and middle-income countries. Yet, most studies focus on Non-Hispanic white (NHW) populations from high-income countries. This study investigates plasma proteomic signatures associated with amyloid pathology in African populations. Nigerian older adults from the VALIANT study and participants from a Tanzanian study, with available biomarker quantification in plasma are employed. For proteomic comparison, participants from the Canadian TRIAD cohort are included, capturing a distinct population. Here, we show that multiple proteins are differentially abundant in the plasma of p-tau217-positive individuals and in the different cognitive groups, with findings largely consistent amongst African cohorts. Comorbidities are significantly associated with protein levels and differences in plasma biomarkers levels are found between sexes. Lastly, VALIANT and TRIAD show both shared and unique protein profiles in relation to amyloid-pathology. These findings support the utility of fluid biomarkers in ADRD in African populations.


  • Open Access

    Carotid arteries in cerebral small vessel disease and dementia

    by Erika Kitajima, Ashley Suwanda, Dan Jobson, Louise Allan, Kian Paydar, Gan Han, Kazuo Washida, Masafumi Ihara, Pazhanichamy Kalailingam, Yoshiki Hase, et al.

    Carotid artery disease (CAD) is a recognised cause of stroke. However, the relationships between CAD, cerebral small vessel disease (SVD) and dementia remain unclear. We hypothesised that CAD in older individuals contributes to cerebral SVD pathology by altering cerebral perfusion. We performed a clinicopathological study in patients from the Cognitive Function After Stroke (CogFAST) study and prospectively recruited patients with various dementia diagnoses and evidence of cerebral SVD. In addition to brain tissues, we collected postmortem samples of the internal carotid arteries (ICA) from these cohorts in the Newcastle Brain Tissue Resource. Standard neuropathological examination was performed for diagnosis and assignment of the cases per current diagnostic criteria for vascular and neurodegenerative dementias, which were assessed for the presence of vascular pathology including the degree of stenosis and sclerosis in vascular tissues. We evaluated a total of 159 ICA samples and brain tissues from all cases with evidence of SVD. Severity of ICA stenosis and sclerotic index correlated strongly with both clinical stroke and brain infarction ( P < 0.001). More than 90% of the subjects had one subtype of ICA lesion in the order: intimal thickening > fibrocalcific > fibrous cap (thick) > fibrous cap (thin) > thrombus group with a strong inflammatory reaction in fibrocalcific atheromas. Regression analyses showed that ICA stenosis was positively correlated to both SVD pathology scores ( P < 0.034) and the total number of vascular lesions ( P < 0.001). ICA stenosis was also related to dementia caused by cerebrovascular disease ( P < 0.001) and by mixed pathologies characterised by Alzheimer’s disease and SVD ( P = 0.025). Severity of stenosis was related to subcortical and white matter (WM) vascular lesions within the anterior circulation. ICA stenosis and sclerosis were moreover correlated with the total intracranial artery pathology scores ( P < 0.001). In the CogFAST group analysis, we observed that MMSE and CAMCOG scores were lower in subjects with moderate to severe stenosis scores compared to the mild stenosis group ( P < 0.05). In these CogFAST cases, by far the majority of lesions in the WM were small in size (< 5 mm, range 72–91%) but not in the cortex or basal ganglia and thalamus. Linear regression analysis further indicated that there were greater numbers of these small lesions in the WM with increasing severity of ICA stenosis ( P < 0.05). Our observations suggest carotid atherosclerosis promotes cerebral SVD types of change within the intracerebral arteries. It is conceivable that extracranial ICA pathology may influence perfusion and integrity of subcortical structures including the deep WM.


  • The rise and rise of vascular dysfunction in Alzheimer’s disease

    by Raj N Kalaria

    This scientific commentary refers to ‘Post-mortem evidence of pathogenic angiogenesis and abnormal vascular function in early Alzheimer's disease’ by Asby et al. (https://doi.org/10.1093/brain/awaf394).

  • Open Access

    High vulnerability of medial prefrontal pyramidal neurons in post‐stroke, vascular, Alzheimer's disease, and aging‐related dementias

    by Dan D. Jobson, Yoshiki Hase, Lauren Walker, Tuomo Polvikoski, Ahmad A. Khundakar, Louise Allan, Raj N. Kalaria

    INTRODUCTION: The medial prefrontal cortex (mPFC) is critical for executive function, behavioral inhibition, and memory. Its high vulnerability to dementia, compared to other prefrontal regions, remains unclear. METHODS: We analyzed post mortem brain tissue from 118 older subjects, including post‐stroke survivors, Alzheimer's disease; vascular, mixed, and frontotemporal dementia (FTD); and cognitively unimpaired controls. Three‐dimensional stereology was used to assess pyramidal neuron densities and volumes in mPFC layers III and V. Immunohistochemistry evaluated metabolic dysfunction via cytochrome c oxidase subunit 1 (COX1), cytochrome c oxidase subunit 4 (COX4), and 78 kDa glucose‐regulated protein expression. RESULTS: Pyramidal neuron densities were lowered by ≈ 45% and volumes by ≈ 37% within all dementia groups relative to controls, except for FTD densities. COX1 and COX4 mitochondrial markers were consistently reduced across dementias. Neuronal densities declined with age, especially in the sixth decade of life. Other prefrontal areas were less affected. DISCUSSION: The mPFC shows high neuronal vulnerability in dementia, while suggesting a vascular–metabolic mechanism, with implications for targeted therapeutic strategies. Highlights: Severe pyramidal neuron loss and atrophy arose in the medial prefrontal cortex. Neuronal morphometric changes correlated with cognitive status or aging effects. Metabolic changes decreased by the greatest extent in vascular‐associated dementias. Metabolic neuronal markers correlated with aging and frontal vascular pathology.


  • Open Access

    Impairment of hippocampal gamma oscillations, mitochondria and neurovascular function in CADASIL

    by Wenchao Shao, Daniel V Oliveira, Luana Naia, Yue Li, Katrine Dahl Bjørnholm, Arturo G Isla, Per Uhlén, Raj Kalaria, Saskia A J Lesnik Oberstein, Urban Lendahl, et al.

    Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is a small vessel disease caused by cysteine-altering NOTCH3 gene variants, leading to vascular smooth muscle cell degeneration, compromised cerebral blood flow, subcortical ischemic infarcts, cognitive decline, and often ultimately vascular dementia. Little is known about the cellular and molecular effects downstream of the cerebral ischemia in CADASIL, or whether brain regions known to be involved in dementia, such as the hippocampus, are particularly susceptible to such pathological downstream changes. In this study, we used a humanized CADASIL mouse model harbouring the p.(Arg182Cys) variant (R182C-TgN3), post-mortem human CADASIL brain sections with four different NOTCH3 gene variants and primary human cerebral vascular smooth muscle cells (VSMCs) harbouring the p.R133C NOTCH3 variant as primary cellular models to characterise the properties and contribution of mutant VSMCs to cognitive impairment. To specifically evaluate neuronal, mitochondrial and neurovascular function, we performed ex vivo electrophysiology, immunohistochemistry (confocal and iDISCO+ methods), western blotting, Seahorse assay, quantitative polymerase chain reaction (qPCR), and single-cell RNA sequencing. In the CADASIL mice, hippocampal gamma oscillation patterns were impaired along with significant decreases in neuronal fiber length and aberrant neuronal morphology. The latter two phenotypes were also observed in post-mortem brain tissue from CADASIL patients. Consistent with these findings, we noted significantly lower levels of mitochondrial respiratory complexes in the CADASIL mouse hippocampus, isolated mouse brain vessels and primary human cerebral VSMCs. The human cerebral VSMCs exhibited reduced oxygen consumption rates leading to reduced ATP production as well as decreased glycolytic capacity in conjunction with increased pro-inflammatory gene expression, suggesting a broader impact on cellular energy metabolism and a neuroinflammatory process. In the CADASIL mice, we also observed extensive accumulation of the NOTCH3 extracellular domain in hippocampal vessels. Light sheet imaging with iDISCO+ clearing demonstrated substantial VSMC loss and reduced vessel density in the hippocampus at 9 months of age. Additionally, 3D imaging showed increased microglial attachment to vessels and enlargement of the size of the vessel-associated microglia in CADASIL mice. Single-cell RNA sequencing revealed a microglial subcluster expressing genes involved in mitochondrial respiration and inflammation. Collectively, our results reveal how small vessel pathology in CADASIL leads to significant neuronal pathology in the hippocampus involving metabolic and neuroinflammatory changes and highlight the critical role of the neurovascular unit. Our findings pave the way for future research and potential therapeutic strategies.


  • Open Access

    The Vascular Hypothesis of Dementia, including Alzheimer's Disease, and Risk Factors for VaD and AD in African Populations

    by Raj Kalaria

    Alzheimer disease (AD) is the considered the most common cause of dementia second to vascular dementia (VaD) worldwide. AD and VaD are multifactorial conditions also influenced by genetic and environmental factors that accelerate the global burden of cognitive impairment and dementia in an ever‐increasing ageing population even in the LMICs. Despite the best efforts to create the clinical biological construct of AD, post‐mortem findings in >80% of probable AD cases show variable degrees of vascular pathology. Frequencies of brain white matter changes explained by a vascular cause rise exponentially from as high as 20% in 60‐year‐olds with almost doubling every decade thereafter in western populations. While these frequencies from imaging studies are not known among LMIC populations, it is expected the burden is high. For example, estimates in the burden of small vessel disease markers in the data from the INTERSTROKE studies suggest incidence of ischaemic or lacunar strokes was 4.7‐fold greater in LMICs than in HICs. This translates to a high burden of vascular related cognitive impairment in Africa. Hypertension and diabetes mellitus are the main modifiable risk factors for the vascular disease. It is not clear in what ways other risks contribute to the vascular burden, but the harmful effects of hypertension are mediated by sustained structural changes in smaller arteries leading to arteriolosclerosis and fluctuations in cerebral perfusion. Cerebrovascular changes particularly arteriolosclerosis rather than infarction(s) appear early and amyloid plaque accretion occurs primarily before the onset of cognitive deficits, whereas neurofibrillary tangles, neuron loss, and particularly synaptic loss, parallel the progression of cognitive decline. The combination of vascular pathology and neurodegenerative changes are additive at each level of pathology lowering the threshold for development of AD dementia. Considering recent large sample studies, could AD therefore result from two different lobar processes such that vascular factors or disease affects the frontal lobe whereas neurodegenerative pathologies largely propagate from the temporal lobe even in African populations? Vascular disease remains a major contributor to morbidity and mortality, the whole burden of dementia can be reduced by vigorously tackling vascular risk factors at the individual, community and population level in Africa.